Frazis Capital Podcast

Timestamps  ·      0:32 – Our fast-growing portfolio companies ·      2:21 - Frazis life sciences strategy update ·      5:18 – RNAi Biology ·      7:15 – Alnylam: RNAi clinical development pipeline and recent execution ·      8:16 – Timing and valuation in life sciences ·      9:26 – What do we think of CRISPER? ·      11:03 – Companies targeting sickle cell disease ·      11:56 – Companies targe...

Michael Frazis discusses the growth sell-off in equities as of 15 May 2021.

Dr. Robert Stretch is a specialist in Pulmonary, Critical Care & Sleep Medicine. After graduating from Yale School of Medicine in 2014, he completed subspecialty training at BIDMC, a Harvard teaching hospital in Boston, and UCLA Medical Center in Los Angeles. Timestamps 0:05 – Introducing Robert Stretch 0:25 – Robert’s journey studying medicine in the US 3:40 – Findings when working on the MIM...

0:15 – Introduction to Frazis Capital Partners. 1:45 – Sell-off trends and SPAC’s. 3:57 – Growth stocks outperforming tech indices. 6:45 – Standpoint on growth stocks. 9:18 – Software’s strong run. 11:05 – Multiple contractions and what this means. 13:30 – Teladoc Health. 14:20 – View on Appharvest. 16:45 – Batteries & developments in the lithium space. 18:30 – Thoughts on DermTech. 19:58 – Ch...

Brian Hartzer joins us to talk about his new book 'The Leadership Star', available from Amazon .  Brian was CEO of Westpac from 2014-2020. For those who don't know Westpac is Australia's second largest bank with over $800 billion of assets.  Brian discusses his 'Leadership Star' framework and pivotal moments in Australia's banking history. Brian also shares his views on cryptocurrency, n...

Michael Frazis gives an update on SPACs, rising interest rates, tech valuations and what might happen next. Timestamps  1:35 - Quick review of 2021   2:30 - Thoughts on Cathie Wood and ARK  3:59 - Expansions and contractions in software multiples  7:40 - Snowflake   8:47 - SPACs: why we like them and why they're dangerous (hint: the same reason) 12:02 - Why we ho...

January 2021 - one of the more amusing weeks of finance.  0:57 - The short squeeze 2:31 - The reality of Robinhood's 'free' trades 5:08 - The hidden consequences of Hedge Fund strategy 6:51 - How useful is management access? 9:56 - The gamma squeeze 12:15 - How this forced people to rethink how they discuss finance? 13:39 - Is the squeeze squoze? 14:37 - Timing and recovery 15:40 - Our strate...

1.40 - Quick review of 2020  2.35 - How to survive huge market swings like March 2020 and 2008-2009  3.45 - Discussion on support mechanisms in place in equity markets (central banks, fiscal stimulus, actions by management teams, etc)  5.45 - Current investment strategy is to stay invested & make sure we are constantly holding winners  7.35 - Sound fundamental reasons why c...

Terry Hau interviewed us for HedgeVista.

Jackie Vullinghs @ Airtree 0:11 - Introducing Jackie 0:54 - University in Australia vs the UK 3:08 - Interviewing at Oxford and Cambridge 3:56 - Approach to VC interviews with company founders 5:55 - Jackie discusses AirTree's key portfolio focus (digital health, fintech, consumer) 6:48 - Companies are staying private for longer, is that good or bad? 8:38 - How sustainable are the accelerations of...

Jarred Shein joins us to talk digital health. Jarred has invested in digital health at MH Carnegie and Qure, an Israeli based VC fund.  0:20 - Introducing Jarred 1:00 - Jarred's education and background.  1:45 - Jarred's studies of nanotechnology, specifically biochemistry  2:30 - Jarred's thesis on biosensor devices and how it relates to Startrek 3:55 - End of university job with M...

Sam Rich joins us to talk security, Crowdstrike, travel names, and how we're positioning the portfolio.

We discuss the current landscape and a couple of choice earnings reports.  0:20 – Introducing Joel Tomaino 1:10 – The structural shift to e-commerce 1:30 – Government stimulus and the diverse impacts of the current economic crisis 2:30 – How long will stimulus benefits and exacerbated e-commerce growth rates last 3:30 – Australian e-commerce plays, including Redbubble (ASX:RBL) 4:40 – E-comme...

Chris Gosselin from Australian Fund Monitors ( https://www.fundmonitors.com/landing.php ) interviewed us about the fund and strategy.  0:00 - Introducing Michael Frazis 1:12 - Michael introduces Frazis Capital and describes its core investment requirements (Customer love, explosive growth and market leadership) 2:45 - The opportunity presented by high growth companies with ugly financial stat...

Companies with brilliant products and broad customer support are faring significantly better than mature incumbents.  One of the fund's newest holdings satisfies our three core criteria: Exponential growth, products that customers truly love, genuine market leadership.

Gaming is one of the more exciting industries in technology right now. We discuss the opportunities and precedents for Twitch and streaming phenomenon.  Ben also takes us through leading chipmakers like NVDIA.  0:32 - Long term trends for Nvidia 2:16 - Demand for Nvidia GPU's in Data centres 3:03 - Use of Nvidia chips for Crypto mining 4:38 - Semiconductors are on the forefront for every...

Peter Stevens rejoins us to discuss some of our environmentally friendly investments. 0:30 - The continued dispersion between technology and the rest of the market 0:50 - The successes of Pinduoduo, Carvana and Afterpay 1:28 - Frazis Capital's successful diversification away from a highly concentrated portfolio 2:33 - Comparing today's hot tech businesses with the hot auto businesses of the past 3...

Alexander began his career investing in technology for UK funds management giant Neptune, before joining London-based VC fund Redline Capital. It's rare indeed to speak to someone with experience across the public and private side of tech investing.  We had a fascinating chat covering robotic process automation, innovation investing, and life in venture capital vs public markets.  https:...

Eti Amegor of Axius Partners & www.suitsandkicks.com joins us to talk allocating and investing in the strange current environment. 0:52 - Opportunities during the coronavirus 1:55 - Current investor trends regarding liquidity 3:30 - The new private equity fund being launched by Eti's firm 6:30 - Why the coronavirus is the best environment for active investment managers 8:00 - Life Sciences sto...

Peter Stevens joins us once again - and will upload notes for this shortly. 

Michael Frazis and Peter Stevens discuss the latest developments.

Peter Stevens joins us to talk about the market sell-off, how we're positioned, and interesting opportunities that we've found.  If you'd like to know more about us see: www.fraziscapitalpartners.com Peter writes his own market commentary here:  https://insufficientcapital.com/ 0:24 – Peter wipes away his tears 0:50 – There’s growth and then there’s growth (e.g. Afterpay vs Zip) 1:30 – W...

Three things you didn't know about the the virus, an Aussie company that stands to benefit, and two in the United States. Afterpay's results... this was a quick one, but a good one. If you'd like to know more about us see: www.fraziscapitalpartners.com You can find Claude at  www.arichlife.com.au 0:50 – Michael gives an update on the underlying science of the latest coronavirus 1:44 – The imp...

Episode 23: Time to sell? Mike and Claude go through EML, Shopify, Wisetech and other cult stocks in the market right now. If you'd like to know more about us see: www.fraziscapitalpartners.com 1:08 - Michael and Claude discuss EML Payments (ASX:EML) 1:44 - The ethical dilemma of EML’s gambling exposure 2:40 - Problems relating to the sale high growth stocks 3:16 - EML’s acquisition of Prepaid Fin...

Mike and Claude from A Rich Life ( https://arichlife.com.au/ ) talk Australian growth stocks for the next decade.  If you'd like to know more about us see: www.fraziscapitalpartners.com 0:38 - Claude's background and time at Motley Fool 4:30 - Pro Medicus (PME:ASX) recommendation and discussion 6:38 - Claude touches on his investment style 8:08 - Pro Medicus as a platform business rather than...